Document is current
Any future updates will be listed below
-
Authors
Kong, Fanyi https://orcid.org/0000-0001-5522-3154
Buse, Dawn C. https://orcid.org/0000-0002-3784-6144
Zhu, Guoliang https://orcid.org/0000-0002-0278-9493
Xu, Jingjing https://orcid.org/0000-0003-0390-4120
-
Funding
Funding for this research was provided by:
The present study was supported by the Health Commission of Yunnan Province, China, Provincial Key Clinical Specialty Development Program during the 14th Five-Year Plan Period.
- License Information
-
More Information
Article History
Received: 28 July 2024
Accepted: 24 September 2024
First Online: 7 October 2024
Declarations
:
: All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.
: KF, JX and GZ declare that there are no conflicts of interest.DCB has grants from Amgen, the National Headache Foundation and the FDA. She has been a consultant for Amgen/Novartis, Allergan/Abbvie, Biohaven, Lilly, Lundbeck, Pfizer, Theranica and Teva. She is on the editorial board of Current Pain and Headache Reports.
